Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
Analytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesEureka AI à l'intérieur
Services professionnels
Témoignages clients
Blog
Rapport mondial sur l'innovation
Glossaire
Newsroom
Webinaires et formations
Frontière
Communauté d'utilisateurs
Confiance et sécurité
PatentBench
LLM
Centre d'aide
Carrières
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport How to evaluate hallucination rate in LLMs for high-stakes engineering decisions: patent-backed methods covering pre-generation scoring, VAE detection, and composite health frameworks.
Article | Rapport Analyse 70+ DOE patents (2005–2026): EUV lithography zone plates, AR/VR waveguide gratings, ophthalmic DOEs, and the key assignees shaping the 2026 landscape.
Article | Rapport How does RLHF differ from DPO in LLM fine-tuning? A patent-backed technical comparison of architectures, tradeoffs, and hybrid approaches across 60+ filings.
Article | Rapport How checkpoint combinations, ADC platforms, and VEGFR-targeted approaches are reshaping the HCC drug pipeline — patent and literature intelligence from PatSnap Eureka.
Article | Rapport A 2026 patent landscape of hydrothermal liquefaction (HTL) technology: reactor design, feedstock trends, key assignees, and emerging IP white spaces.
Article | Rapport How does RLHF differ from DPO in LLM fine-tuning? A patent-backed technical comparison of architectures, tradeoffs, and hybrid approaches across 60+ filings.
Article | Rapport How light-sensitive opsins are reshaping drug discovery in 2026: from AAV gene therapy for blindness to in vivo neuronal screening platforms and GPCR target validation tools.
Article | Rapport How to achieve sub-10 millisecond thermal runaway detection in battery management systems: hardware circuits, hierarchical architectures, EIS, and multi-sensor fusion strategies.
Article | Rapport Beta-3 agonists, muscarinic antagonists, and BTX combination approaches are reshaping the OAB drug pipeline. Explore the patent landscape and emerging targets.
Article | Rapport A 2026 patent landscape analysis of microwave energy harvesting: rectenna systems, IRS-assisted WPT, SWIPT beamforming, and ambient RF harvesting across IoT, 5G, and aerospace.
Article | Rapport Electrochemical ammonia synthesis (eNRR) is reshaping green chemistry. Explore the 2026 patent landscape: catalysts, plasma hybrids, NOₓ routes, and geographic IP trends.
Article | Rapport How active cell balancing topologies recover usable capacity in high-voltage EV battery packs — circuit architectures, hierarchical control, and key patent trends.
Article | Rapport How active cell balancing topologies recover usable capacity in high-voltage EV battery packs — circuit architectures, hierarchical control, and key patent trends.
Article | Rapport A deep-dive into the 2026 TENG patent landscape: key assignees, material advances, power management IP, hybrid devices, and emerging application domains.
Article | Rapport Oral GnRH antagonists, SPRMs, and non-surgical approaches are reshaping the uterine fibroids drug pipeline. Explore patent signals, key compounds, and strategic IP trends.